Access
This article is part of Nature's premium content.
Published online 21 November 2007 | Nature | doi:10.1038/450471a
Trip into the unknown
A plant in Uganda hopes to sell cut-price drugs by taking advantage of exemptions from rules that protect patents. But its operators face major obstacles, as Tatum Anderson reports.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email webadmin@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
There are currently no comments.
